Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 12 Lymphoma, Large B-Cell, Diffuse 12 Sarcoma, Ewing 4 Lymphoma, B-Cell 4 Recurrence 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Osteosarcoma 3 Neurofibrosarcoma 3 Lymphoma, Non-Hodgkin 3 Liposarcoma 3 Hodgkin Disease 3 Fibrosarcoma 3 Sarcoma, Synovial 2 Sarcoma, Clear Cell 2 Rhabdomyosarcoma 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Neuroblastoma 2 Nerve Sheath Neoplasms 2 Neoplasms, Germ Cell and Embryonal 2 Lymphoma, Follicular 2 Lymphoma 2 Leiomyosarcoma 2 Histiocytoma, Malignant Fibrous 2 Histiocytoma, Angiomatoid Fibrous 2 Hemangiosarcoma 2 Granuloma, Plasma Cell 2 Desmoplastic Small Round Cell Tumor 2 Dermatofibrosarcoma 2 Chondrosarcoma, Extraskeletal Myxoid 2 Burkitt Lymphoma 2

Interventions

Diathermy 6 Radiotherapy 2 Surgical Procedures, Operative 1 Solutions 1 Saline Solution 1 Patient Reported Outcome Measures 1 Paclitaxel 1 Immunotherapy 1 Ifosfamide 1 Hyperthermia, Induced 1 Hydrogen Peroxide 1 Doxorubicin 1 Dacarbazine 1 Cryotherapy 1 Carboplatin 1 AC protocol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Hyperthermia × Ifosfamide × 1 year × Clear all

NCT06835049 2025-12-30

TNT-HYPE

Swiss Cancer Institute

Phase 2 Recruiting

Hyperthermia, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡